Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma × bexmarilimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Doxorubicin 119 Ifosfamide 70 Radiotherapy 64 Cyclophosphamide 61 Gemcitabine 53 Filgrastim 46 Docetaxel 34 pazopanib 33 Etoposide 33 pembrolizumab 32 Trabectedin 31 Vincristine 30 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Temozolomide 17 Radiation 16 Mesna 16 Melphalan 16 Bevacizumab 16 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Dactinomycin 15 Biopsy 15 eribulin 14 Topotecan 14 Surgical Procedures, Operative 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07460986 2026-03-10

BEXAR

MedSIR

Phase 1/2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡